pISSN 1976-2283
eISSN 2005-1212

Cited by CrossRef (116)

  1. Jian Li, Boxun Jin, Tiezheng Wang, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song, Ning Li. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. CBM 2019:1
    https://doi.org/10.3233/CBM-181970
  2. Hiroaki Takaya, Tadashi Namisaki, Naotaka Shimozato, Kosuke Kaji, Mitsuteru Kitade, Kei Moriya, Shinya Sato, Hideto Kawaratani, Takemi Akahane, Masanori Matsumoto, Hitoshi Yoshiji. ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma. WJGO 2019;11:424
    https://doi.org/10.4251/wjgo.v11.i5.424
  3. . .
    https://doi.org/
  4. In Fun Li, Jen‐Chien Huang, Jyh‐Jou Chen, Tseng En Wang, Sheng‐Shiung Huang, Shiow‐Luan Tsay. Factors related to the quality of life in liver cancer patients during treatment phase: A follow‐up study. Eur J Cancer Care 2019;28
    https://doi.org/10.1111/ecc.13146
  5. J.-Y. Lee, G. Kim, Y.-H. Lee, B.-W. Lee, B.-S. Cha, C.M. Nam, E.S. Kang. Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide. Diabetes & Metabolism 2019;45:83
    https://doi.org/10.1016/j.diabet.2017.06.007
  6. Susan L Stewart, Sandy L Kwong, Christopher L Bowlus, Tung T Nguyen, Annette E Maxwell, Roshan Bastani, Eric W Chak, Moon S Chen Jr. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. WJG 2016;22:8584
    https://doi.org/10.3748/wjg.v22.i38.8584
  7. Zhi Qu, Qi Ling, Jill Gwiasda, Xiao Xu, Harald Schrem, Jan Beneke, Alexander Kaltenborn, Christian Krauth, Heiko Mix, Jürgen Klempnauer, Nikos Emmanouilidis. Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany. Langenbecks Arch Surg 2018;403:643
    https://doi.org/10.1007/s00423-018-1696-8
  8. Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. Cell death in a co-culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine. 2017;13:258
    https://doi.org/10.3892/ol.2016.5454
  9. Kuan-Chun Hsueh, Chia-Liang Lin, Jai-Nien Tung, Shun-Fa Yang, Yi-Hsien Hsieh. Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells. Environmental Toxicology 2018
    https://doi.org/10.1002/tox.22576
  10. Yi-Hsiu Chung, Ching-Fang Yu, Shao-Chieh Chiu, Han Chiu, Shin-Ting Hsu, Ching-Rong Wu, Chung-Lin Yang, Ji-Hong Hong, Tzu-Chen Yen, Fang-Hsin Chen. Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation. Eur J Nucl Med Mol Imaging 2019;46:1733
    https://doi.org/10.1007/s00259-019-04318-3
  11. Thanate Kattipatanapong, Hideyuki Nishiofuku, Toshihiro Tanaka, Takeshi Sato, Tetsuya Masada, Shota Tatsumoto, Takeshi Matsumoto, Kimihiko Kichikawa. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2019
    https://doi.org/10.1007/s00270-019-02365-9
  12. Yuanmin Pei, Xueling Sun, Xiwei Guo, Huashan Yin, Le Wang, Fugu Tian, Hongxi Jing, Xiaobo Liang, Jun Xu, Pengcheng Shi. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells. 2017;38:2205
    https://doi.org/10.3892/or.2017.5887
  13. Mohammed Nihal Hasan, Hani Choudhry, Syed Shoeb Razvi, Said Salama Moselhy, Taha Abduallah Kumosani, Mazin A. Zamzami, Ziad Omran, Majed A. Halwani, Salim Al-Babili, Khalid Omer Abualnaja, Abdulrahman Labeed Al-Malki, Mahmoud Alhosin, Tadao Asami. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells. Bioorganic & Medicinal Chemistry Letters 2018;28:1077
    https://doi.org/10.1016/j.bmcl.2018.02.016
  14. Keungmo Yang, Pil S. Sung, Young K. You, Dong G. Kim, Jung S. Oh, Ho J. Chun, Jeong W. Jang, Si H. Bae, Jong Y. Choi, Seung K. Yoon. Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response. HPB 2019;21:1718
    https://doi.org/10.1016/j.hpb.2019.04.017
  15. Jin Chen, Xue Li, Qi Cheng, Deng Ning, Jie Ma, Zhi-Ping Zhang, Xiao-Ping Chen, Li Jiang. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. J. Cell. Biochem. 2018;119:2368
    https://doi.org/10.1002/jcb.26400
  16. Fuu-Jen Tsai, Xiang Liu, Chao-Jung Chen, Te-Mao Li, Jian-Shiun Chiou, Po-Heng Chuang, Cheng-Hang Ko, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Wen-Miin Liang, Ying-Ju Lin. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan. Complementary Therapies in Medicine 2019;47:102213
    https://doi.org/10.1016/j.ctim.2019.102213
  17. Yuanlong Cao, Yuanyuan Ding, Liping Zhang, Gang Shi, Xinxin Sang, Caihua Ni. Preparation of surface-modified, micrometer-sized carboxymethyl chitosan drug-loaded microspheres. J. Appl. Polym. Sci. 2018;135:45731
    https://doi.org/10.1002/app.45731
  18. Wei Guo, Jihan Huang, Ning Wang, Hor-Yue Tan, Fan Cheung, Feiyu Chen, Yibin Feng. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.01185
  19. Ran-Xu Zhu, Alfred Sze Lok Cheng, Henry Lik Yuen Chan, Dong-Ye Yang, Wai-Kay Seto. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis. WJG 2019;25:4673
    https://doi.org/10.3748/wjg.v25.i32.4673
  20. Chi-Yuan Chen, Chin-Chuan Chen, Tzong-Ming Shieh, Chuen Hsueh, Shu-Huei Wang, Yann-Lii Leu, Jang-Hau Lian, Tong-Hong Wang. Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5. IJMS 2018;19:380
    https://doi.org/10.3390/ijms19020380
  21. Yajie Wang, Hua Sun, Zhiyan Xiao, Dan Zhang, Xiuqi Bao, Ning Wei. XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma. Sci Rep 2017;7
    https://doi.org/10.1038/s41598-017-10577-7
  22. San-Yuan Chen, Ying-Ray Lee, Ming-Chia Hsieh, Hany A. Omar, Yen-Ni Teng, Ching-Yen Lin, Jui-Hsiang Hung. Enhancing the Anticancer Activity of Antrodia cinnamomea in Hepatocellular Carcinoma Cells via Cocultivation With Ginger: The Impact on Cancer Cell Survival Pathways. Front. Pharmacol. 2018;9
    https://doi.org/10.3389/fphar.2018.00780
  23. Ryan B. Schwope, Matthew Katz, Timothy Russell, Michael J. Reiter, Christopher J. Lisanti. The many faces of cirrhosis. Abdom Radiol 2019
    https://doi.org/10.1007/s00261-019-02095-z
  24. Cheng-En Hsieh, Bhanu Prasad Venkatesulu, Ching-Hsin Lee, Sheng-Ping Hung, Pei-Fong Wong, Sathvik Panambur Aithala, Byung Kyu Kim, Arvind Rao, Joseph Tung-Chieh Chang, Ngan-Ming Tsang, Chun-Chieh Wang, Chung-Chi Lee, Chen-Chun Lin, Jeng-Hwei Tseng, Wen-Chi Chou, Yu-Chao Wang, Sunil Krishnan, Ji-Hong Hong. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy. International Journal of Radiation Oncology*Biology*Physics 2019;105:73
    https://doi.org/10.1016/j.ijrobp.2019.02.032
  25. Ning Li, Ling Li, Yongshun Chen. The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2018;2018:1
    https://doi.org/10.1155/2018/3478305
  26. Kruti Dalal, Priyanka Khorate, Bhavik Dalal, Rahul Chavan, Shobna Bhatia, Avinash Kale, Akash Shukla, Aruna Shankarkumar. Differentially expressed serum host proteins in hepatitis B and C viral infections. VirusDis. 2018;29:468
    https://doi.org/10.1007/s13337-018-0484-y
  27. Ian C Roberts-Thomson, Thomas Lung. Cost-effective options for the prevention and management of gastrointestinal and liver disease in the Asia-Pacific region. Journal of Gastroenterology and Hepatology 2018;33:121
    https://doi.org/10.1111/jgh.13925
  28. Wei Dai, Jia-Liang Dai, Mao-Hua Tang, Mu-Shi Ye, Shuo Fang. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis. WJG 2019;25:5789
    https://doi.org/10.3748/wjg.v25.i38.5789
  29. Minqian Shen, Jingyi Cao, Haifei Shi. Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing. International Journal of Endocrinology 2018;2018:1
    https://doi.org/10.1155/2018/5789127
  30. Jae-Jun Shim, Chi Hyuck Oh, Jung Wook Kim, Chang Kyun Lee, Byung-Ho Kim. Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy. Scandinavian Journal of Gastroenterology 2017:1
    https://doi.org/10.1080/00365521.2017.1335773
  31. Wenzhe Si, Yang Zhao, Jiansuo Zhou, Qiang Zhang, Yuan Zhang. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101. Experimental Cell Research 2019;379:1
    https://doi.org/10.1016/j.yexcr.2019.03.017
  32. Ping Huang, Yu Hua Zhang, Xiao Wei Zheng, Yu Jia Liu, Hong Zhang, Luo Fang, Yi Wen Zhang, Chang Yang, Khairul Islam, Chao Wang, Hua Naranmandura. Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways. Metallomics 2017;9:1756
    https://doi.org/10.1039/C7MT00179G
  33. Ken Min Chin, John Carson Allen, Jin Yao Teo, Juinn Huar Kam, Ek Khoon Tan, Yexin Koh, Brian K. P. Goh, Peng Chung Cheow, Prema Raj, Kah Hoe Pierce Chow, Yaw Fui Alexander Chung, London Lucien Ooi, Chung Yip Chan, Ser Yee Lee. Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:185
    https://doi.org/10.14701/ahbps.2018.22.3.185
  34. Xiaozhang Shen, Sicong Ma, Xiaoyin Tang, Tao Wang, Xingxing Qi, Jiachang Chi, Zhi Wang, Dan Cui, Yuan Zhang, Ping Li, Bo Zhai. Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT). Medicine 2018;97:e11618
    https://doi.org/10.1097/MD.0000000000011618
  35. Yuchong Peng, Weiye Leng, Shigang Duan, Ming Hong. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p. Biomedicine & Pharmacotherapy 2019;116:109027
    https://doi.org/10.1016/j.biopha.2019.109027
  36. Ariraman Subastri, Arumugam Suyavaran, Ezhuthupurakkal Preedia Babu, Subramaniyam Nithyananthan, Rajamani Barathidasan, Chinnasamy Thirunavukkarasu. Troxerutin with copper generates oxidative stress in cancer cells: Its possible chemotherapeutic mechanism against hepatocellular carcinoma. J Cell Physiol 2018;233:1775
    https://doi.org/10.1002/jcp.26061
  37. Rolf Teschke. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opinion on Pharmacotherapy 2018;19:779
    https://doi.org/10.1080/14656566.2018.1465929
  38. Yingchao Wang, Gaoxiong Wang, Xionghong Tan, Kun Ke, Bixing Zhao, Niangmei Cheng, Yuan Dang, Naishun Liao, Fei Wang, Xiaoyuan Zheng, Qin Li, Xiaolong Liu, Jingfeng Liu. MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53. Oncogenesis 2019;8
    https://doi.org/10.1038/s41389-019-0176-5
  39. Ling Li, Huijia Zhao, Binyao Chen, Kang Huang, Zhuowen Hao, Zhipeng Fan, Gongpeng Sun, Jianguo Wu, Ning Li, Qifa Ye, Jiang Yue. Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma. Journal of Oncology 2019;2019:1
    https://doi.org/10.1155/2019/2531932
  40. An-Ting Liou, Mei-Fang Chen, Chu-Wen Yang. Curcumin Induces p53-Null Hepatoma Cell Line Hep3B Apoptosis through the AKT-PTEN-FOXO4 Pathway. Evidence-Based Complementary and Alternative Medicine 2017;2017:1
    https://doi.org/10.1155/2017/4063865
  41. Ming Xu, Lonbo Zhen, Liumei Lin, Ke Wu, Yifan Wang, Xiujun Cai. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2019
    https://doi.org/10.1016/j.clinre.2019.07.012
  42. Vasanthakumar S, Sasikala P, Padma M, Balachandar V, Venkatesh B, Ganesan S. EpCAM as a novel therapeutic target for hepatocellular carcinoma. Journal of Oncological Sciences 2017;3:71
    https://doi.org/10.1016/j.jons.2017.04.002
  43. Baoyong Wang, Hongwei Chen, Chunfen Zhang, Tian Yang, Qiaofei Zhao, Yifan Yan, Yu Zhang, Feng Xu. Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression. Cancer Biotherapy and Radiopharmaceuticals 2018;33:194
    https://doi.org/10.1089/cbr.2017.2424
  44. Zhao-Yan Liu, Xu-Ying Tan, Qi-Jiong Li, Gong-Cheng Liao, Ai-Ping Fang, Dao-Ming Zhang, Pei-Yan Chen, Xiao-Yan Wang, Yun Luo, Jing-An Long, Rong-Huan Zhong, Hui-Lian Zhu. Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study. Nutr Metab (Lond) 2018;15
    https://doi.org/10.1186/s12986-018-0319-2
  45. Pi-Yi Chang, Chun-Chieh Huang, Chao-Hung Hung, Chih-Yung Yu, Ding-Kwo Wu, Jen-I Hwang, Po-Chin Liang, Reng-Hong Wu, Wei-Lun Tsai, Yih-Jyh Lin, Yi-Sheng Liu, Huei-Lung Liang, Rheun-Chuan Lee, Chien-Hung Chen. Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment. Liver Cancer 2018;7:312
    https://doi.org/10.1159/000487608
  46. Liping Zhang, Ming Liu, Tian Qi, Haili Zhou, Caihua Ni. Preparations and properties of drug-eluting embolization microspheres based on modified gelatin. Soft Materials 2018;16:117
    https://doi.org/10.1080/1539445X.2018.1435552
  47. Nan Cheng, Ju Wu, Min Yin, Jian Xu, Yadong Wang, Xi Chen, Zhequn Nie, Jiajun Yin. LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p. 2019;39
    https://doi.org/10.1042/BSR20190251
  48. Lingling He, Xiaohui Ye, Jiali Ma, Ping Li, Yu Jiang, Julong Hu, Junru Yang, Yuling Zhou, Xiuxia Liang, Yijun Lin, Hongshan Wei. Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy. BMC Gastroenterol 2019;19
    https://doi.org/10.1186/s12876-019-1020-2
  49. Jae Won Chung, Jeong-Sik Yu, Jeong Min Choi, Eun-Suk Cho, Joo Hee Kim, Jae-Joon Chung. Subtraction Images From Portal Venous Phase Gadoxetic Acid–Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018. American Journal of Roentgenology 2019:1
    https://doi.org/10.2214/AJR.18.20797
  50. Yonghao Liang, Qisheng Li, Keli Chen, Wen Ni, Zetao Zhan, Feng Ye, Yiyi Li, Yuan Fang, Fengjiao Zhang, Longhua Chen, Yi Ding. Zinc finger protein 307 functions as a tumor-suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinoma. 2017;38:2229
    https://doi.org/10.3892/or.2017.5868
  51. Xinxin Sang, Meng Zhang, Quanwu Wen, Gang Shi, Liping Zhang, Caihua Ni. Preparation of Drug-Eluting Microspheres Based on Semi-Interpenetrating Polymer Network of Modified Chitosan and Poly(2-acrylamide-2-methylpropanesulfonic acid). Polym. Sci. Ser. A 2019;61:61
    https://doi.org/10.1134/S0965545X19010061
  52. A. Nonpunya, B. Sethabouppha, S. Rufini, N. Weerapreeyakul. Cratoxylum formosum ssp. pruniflorum activates the TRAIL death receptor complex and inhibits topoisomerase I. South African Journal of Botany 2018;114:150
    https://doi.org/10.1016/j.sajb.2017.11.003
  53. Nur Signa A Gumilas, Ika M Harini, Thianty Sylviningrum, Wahyu Djatmiko, Lantip Rujito. Hepatitis B as hepatocellular carcinoma (HCC) risk factor in the south region of Java, Indonesia. J. Phys.: Conf. Ser. 2019;1246:012013
    https://doi.org/10.1088/1742-6596/1246/1/012013
  54. Ming-Hsien Chien, Yung-Chuan Ho, Shun-Fa Yang, Yi-Chieh Yang, Szu-Yu Lai, Wan-Shen Chen, Ming-Jenn Chen, Chao-Bin Yeh. Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression. Environmental Toxicology 2018;33:659
    https://doi.org/10.1002/tox.22551
  55. Shih‐Yung Su, Wen‐Chung Lee. Mortality trends of liver diseases from 1981 to 2016 and the projection to 2035 in Taiwan: An age‐period‐cohort analysis. Liver Int 2019;39:770
    https://doi.org/10.1111/liv.14027
  56. Maryam Salari, Anoshirvan Kazemnejad, Farid Zayeri. Clustering Asian Countries According to the Trend of liver cancer Mortality Rates: an Application of Growth Mixture Models. Iran Red Crescent Med J 2017;19
    https://doi.org/10.5812/ircmj.15107
  57. L. Tang, M. Kamat, A. Shukla, M. Vora, C. Kalal, S. Kottilil, S. Shah. Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C. Interdisciplinary Perspectives on Infectious Diseases 2018;2018:1
    https://doi.org/10.1155/2018/9124604
  58. Liang-jie Fang, Lu-yan Chen, Jun-hui Sun, Jian-ying Zhou. Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China. Analytical Cellular Pathology 2019;2019:1
    https://doi.org/10.1155/2019/4307651
  59. Yan Miao, Ying Zhang, Lihong Yin. Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis. 2018;6:e5477
    https://doi.org/10.7717/peerj.5477
  60. Rinku Dutta, Ram I. Mahato. Recent advances in hepatocellular carcinoma therapy. Pharmacology & Therapeutics 2017;173:106
    https://doi.org/10.1016/j.pharmthera.2017.02.010
  61. Gabriele Ricco, Daniela Cavallone, Chiara Cosma, Gian Paolo Caviglia, Filippo Oliveri, Alessandra Biasiolo, Maria Lorena Abate, Mario Plebani, Antonina Smedile, Ferruccio Bonino, Patrizia Pontisso, Maurizia Rossana Brunetto. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers. CBM 2018;21:603
    https://doi.org/10.3233/CBM-170551
  62. Tian Hu, Jincheng Li, Chuhong Zhang, Xiu lv, Sai Li, Sha He, Hanxing Yan, Yixi Tan, Mingsheng Lei, Meiling Wen, Jianhong Zuo. The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma. Genes & Diseases 2017;4:116
    https://doi.org/10.1016/j.gendis.2017.03.003
  63. Hasibe Vural, Pınar Özden, Ebru Avcı. Ginnalin A and SB203580 show additive effect on Hep-3B hepatocellular carcinoma cell line. 2019;44:78
    https://doi.org/10.1515/tjb-2018-0099
  64. Longbo Zheng, Ming Xu, Junjie Xu, Ke Wu, Qian Fang, Yuelong Liang, Senjun Zhou, Dong Cen, Lin Ji, Weili Han, Xiujun Cai. ELF3 promotes epithelial–mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma. Cell Death Dis 2018;9
    https://doi.org/10.1038/s41419-018-0399-y
  65. Jean-Luc Raoul, Judith Raimbourg, Sandrine Hiret, Xavier Adhoute, Hélène Senellart. Épidémiologie du carcinome hépatocellulaire : simple augmentation d’incidence ou futur drame ?. Bulletin du Cancer 2018;105:502
    https://doi.org/10.1016/j.bulcan.2018.02.003
  66. Angkana Thongkum, Chunjing Wu, Ying-Ying Li, Medhi Wangpaichitr, Panida Navasumrit, Varabhorn Parnlob, Thaniya Sricharunrat, Vajarabhongsa Bhudhisawasdi, Mathuros Ruchirawat, Niramol Savaraj. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma. IJMS 2017;18:1175
    https://doi.org/10.3390/ijms18061175
  67. Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr. High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016. WJH 2018;10:116
    https://doi.org/10.4254/wjh.v10.i1.116
  68. C. Bouvry, X. Palard, J. Edeline, V. Ardisson, P. Loyer, E. Garin, N. Lepareur. Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres. BioMed Research International 2018;2018:1
    https://doi.org/10.1155/2018/1435302
  69. Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, Kosuke Kaji, Keisuke Nakanishi, Yuki Tsuji, Naotaka Shimozato, Kei Moriya, Kenichiro Seki, Yasuhiko Sawada, Soichiro Saikawa, Shinya Sato, Hideto Kawaratani, Takemi Akahane, Ryuichi Noguchi, Masanori Matsumoto, Hitoshi Yoshiji. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma. BMC Gastroenterol 2019;19
    https://doi.org/10.1186/s12876-019-1082-1
  70. Shenghao Wang, Muhammad Kalim, Keying Liang, Jinbiao Zhan. Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinoma. Preparative Biochemistry and Biotechnology 2018;48:435
    https://doi.org/10.1080/10826068.2018.1452258
  71. Nasimudeen R. Jabir, Saheem Ahmad, Shams Tabrez. An insight on the association of glycation with hepatocellular carcinoma. Seminars in Cancer Biology 2018;49:56
    https://doi.org/10.1016/j.semcancer.2017.06.005
  72. J L Raoul, S Faivre, J S Frenel, L Rimassa. Medical oncologists must get more involved in systemic treatment of hepatocellular carcinoma. 2019;30:6
    https://doi.org/10.1093/annonc/mdy471
  73. Ling-Ling He, Xiao-Li Liu, Shuan Zhang, Meng-Ge Li, Xian-Bo Wang, Yu-Yong Jiang, Zhi-Yun Yang. Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter. 2019;7:250
    https://doi.org/10.1093/gastro/goz009
  74. Mandana Rastegar, Haji-Amin Marjani, Yaghoub Yazdani, Majid Shahbazi, Masoud Golalipour, Touraj Farazmandfar. Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line. Adv Pharm Bull 2018;8:63
    https://doi.org/10.15171/apb.2018.008
  75. Omar Abdel-Rahman, Winson Y. Cheung. The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018;2018:1
    https://doi.org/10.1155/2018/4763832
  76. Hyung Soon Lee, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Sang Hoon Ahn, Do Young Kim, Jun Yong Park, Seung Up Kim, Sung Hoon Kim, Dong Sup Yoon, Jae Keun Kim, Jong Won Choi, Soon Sun Kim, Hana Park. Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea. Ann Surg Treat Res 2019;96:275
    https://doi.org/10.4174/astr.2019.96.6.275
  77. Hye Won Lee, Se Rim Oh, Dong Yun Kim, Yechan Jeong, Seungtaek Kim, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park. Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety. Gut and Liver 2018;12:324
    https://doi.org/10.5009/gnl17298
  78. Fei Huang, Junying Chen, Ruilong Lan, Zeng Wang, Ruiqing Chen, Jingan Lin, Lengxi Fu. Hypoxia induced δ-Catenin to enhance mice hepatocellular carcinoma progression via Wnt signaling. Experimental Cell Research 2019;374:94
    https://doi.org/10.1016/j.yexcr.2018.11.011
  79. Ting Xiong, Zihan Li, Xuelong Huang, Kaiqiang Lu, Weiquan Xie, Zhigang Zhou, Jian Tu. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019;316:G598
    https://doi.org/10.1152/ajpgi.00061.2018
  80. Rupal Ojha, Raj Nandani, Nina Chatterjee, Vijay Kumar Prajapati. Circular RNAs. 2019.
    https://doi.org/10.1007/978-981-13-1426-1_12
  81. Qing-guo Xu, Sheng-xian Yuan, Qi-fei Tao, Jian Yu, Jie Cai, Yuan Yang, Xing-gang Guo, Kong-ying Lin, Jin-zhao Ma, De-shu Dai, Zhen-guang Wang, Fang-ming Gu, Ling-hao Zhao, Le-qun Li, Jing-feng Liu, Shu-han Sun, Yun-jin Zang, Hui Liu, Fu Yang, Wei-ping Zhou. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. Journal of Hepatology 2019;70:904
    https://doi.org/10.1016/j.jhep.2019.01.007
  82. Yuan Fang. Circular RNAs as novel biomarkers with regulatory potency in human diseases. Future Science OA 2018;4:FSO314
    https://doi.org/10.4155/fsoa-2018-0036
  83. Chaojie Liang, Kaitong Zhang, Hua Ge, Wei Li, Guangming Li, Jixiang Wu. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis. Clinica Chimica Acta 2018;477:24
    https://doi.org/10.1016/j.cca.2017.11.037
  84. Sahabjada Siddiqui, Rumana Ahmad, Mohsin Ali Khan, Shivbrat Upadhyay, Ishrat Husain, Anand Narain Srivastava. Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-018-36475-0
  85. Yeun-Yoon Kim, Jin-Young Choi, Claude B. Sirlin, Chansik An, Myeong-Jin Kim. Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS). Eur Radiol 2019;29:1124
    https://doi.org/10.1007/s00330-018-5641-6
  86. Ji-Yeon Lee, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang. Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-019-44447-1
  87. Bin Liang, Dan Zhao, Yiming Liu, Xiaopeng Guo, Hongsen Zhang, Lijie Zhang, Chuansheng Zheng. Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model. Drug Deliv. and Transl. Res. 2019
    https://doi.org/10.1007/s13346-019-00672-9
  88. Juferdy Kurniawan, Rino A. Gani, Irsan Hasan, Andri S. Sulaiman, Cosmas R. A. Lesmana, Chyntia O. M. Jasirwan, Kemal F. Kalista, Saut H. H. Nababan, Steven Zulkifly. The Improvement in 1-Year Survival Rate of Patients with Hepatocellular Carcinoma BCLC Stage A and B after the Implementation of Comprehensive Management. J Gastrointest Canc 2019
    https://doi.org/10.1007/s12029-019-00298-7
  89. V.H.F. Lee, J. Seong, S.M. Yoon, T.C.L. Wong, B. Wang, J.L. Zhang, C.L. Chiang, P.P.Y. Ho, L.A. Dawson. Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West. Clinical Oncology 2019;31:560
    https://doi.org/10.1016/j.clon.2019.06.002
  90. Mohammed Y. Alhassani, Samir F. Zohny, Ryan A. Sheikh, Mohammed A. Hassan, Abdulaziz A. Kalantan, Salman Hosawi, Mahmoud Alhosin. Thymoquinone exerts anti-tumor activities on human hepatocellular carcinoma cells: role of angiogenesis-related genes VCAN, Grb2 and EZH2. Eur. J. Cell Sci. 2019:10
    https://doi.org/10.34154/2019-EJCS-0101-10-16/euraass
  91. Bei Wang, Tan-Yang Zhou, Chun-Hui Nie, Da-Long Wan, Shu-Sen Zheng. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer. Biochemical and Biophysical Research Communications 2018;499:156
    https://doi.org/10.1016/j.bbrc.2018.03.091
  92. Yan Wang, Weijia Li, Xiangyu Chen, Ya Li, Peihao Wen, Feng Xu. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2019;111:1297
    https://doi.org/10.1016/j.biopha.2018.12.134
  93. Rena Kaneko, Natsuko Nakazaki, Risa Omori, Yuichiro Yano, Masazumi Ogawa, Yuzuru Sato. Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience. WJH 2018;10:88
    https://doi.org/10.4254/wjh.v10.i1.88
  94. Bingling Dai, Yujiao Ma, Tianfeng Yang, Mengying Fan, Runze Yu, Qi Su, Hongying Wang, Feng Liu, Changhua Yang, Yanmin Zhang. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma. Phytotherapy Research 2019;33:745
    https://doi.org/10.1002/ptr.6267
  95. Liang-Cheng Chen, Wen-Yen Chiou, Hon-Yi Lin, Moon-Sing Lee, Yuan-Chen Lo, Li-Wen Huang, Chun-Ming Chang, Tsung-Hsing Hung, Chih-Wen Lin, Kuo-Chih Tseng, Dai-Wei Liu, Feng-Chun Hsu, Shih-Kai Hung. Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial. BMC Cancer 2019;19
    https://doi.org/10.1186/s12885-019-5461-3
  96. K. Dalal, B. Dalal, S. Bhatia, A. Shukla, A. Shankarkumar. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection. Clinica Chimica Acta 2019;495:309
    https://doi.org/10.1016/j.cca.2019.04.072
  97. Emma B. Holliday, Randa Tao, Zachary Brownlee, Prajnan Das, Sunil Krishnan, Cullen Taniguchi, Bruce D. Minsky, Joseph M. Herman, Ahmed Kaseb, Kanwal Raghav, Claudius Conrad, Jean-Nicholas Vauthey, Thomas A. Aloia, Yun Shin Chun, Christopher H. Crane, Eugene J. Koay. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clinical and Translational Radiation Oncology 2017;4:39
    https://doi.org/10.1016/j.ctro.2017.04.003
  98. Hua Xiang, Lin Long, Yuanhui Yao, Zhiyong Fang, Zhiming Zhang, Yongjin Zhang. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma. Technol Cancer Res Treat 2019;18:153303381983075
    https://doi.org/10.1177/1533033819830751
  99. Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, Naotaka Shimozato, Kosuke Kaji, Yuki Tsuji, Keisuke Nakanishi, Ryuichi Noguchi, Yukihisa Fujinaga, Yasuhiko Sawada, Soichiro Saikawa, Shinya Sato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Hitoshi Yoshiji. Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients. WJGO 2019;11:887
    https://doi.org/10.4251/wjgo.v11.i10.887
  100. Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. 2019.
    https://doi.org/10.1007/978-3-319-89390-7_10
  101. Myat Thu Soe, Yasuaki Shibata, Myo Win Htun, Kuniko Abe, Kyaw Soe, Nay Win Than, Thann Lwin, Myat Phone Kyaw, Takehiko Koji. Immunohistochemical Mapping of Bcl9 Using Two Antibodies that Recognize Different Epitopes Is Useful to Characterize Juvenile Development of Hepatocellular Carcinoma in Myanmar. Acta Histochemica et Cytochemica 2019;52:9
    https://doi.org/10.1267/ahc.18045
  102. Stephannie Shih, Yen-Tsung Huang, Hwai-I Yang. A multiple mediator analysis approach to quantify the effects of the ADH1B and ALDH2 genes on hepatocellular carcinoma risk. Genet. Epidemiol. 2018;42:394
    https://doi.org/10.1002/gepi.22120
  103. Mao-Chi Weng, Mei-Hui Wang, Jai-Jen Tsai, Yu-Cheng Kuo, Yu-Chang Liu, Fei-Ting Hsu, Hsin-Ell Wang. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice. 2018;38
    https://doi.org/10.1042/BSR20171264
  104. Nayantara Orekondy, Sheila Eswaran. Misconceptions Surrounding Hepatocellular Carcinoma. Clinical Liver Disease 2018;12:154
    https://doi.org/10.1002/cld.752
  105. Chun-Yi Lin, Chiung-Wei Liao, Lu-Yen Chu, Kuo-Yang Yen, Long-Bin Jeng, Cheng-Nan Hsu, Cheng-Li Lin, Chia-Hung Kao. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Clinical Nuclear Medicine 2017;42:e183
    https://doi.org/10.1097/RLU.0000000000001545
  106. Ran-Xu Zhu, Alfred Sze Lok Cheng, Henry Lik Yuen Chan, Dong-Ye Yang, Wai-Kay Seto. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis. WJG 2019;25:4715
    https://doi.org/10.3748/wjg.v25.i32.4715
  107. Wei Zhang, Yifei Tan, Li Jiang, Lunan Yan, Jiayin Yang, Bo Li, Tianfu Wen, Hong Wu, WenTao Wang, Mingqing Xu. Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection. International Journal of Surgery 2017;44:160
    https://doi.org/10.1016/j.ijsu.2017.06.041
  108. Yu Xiong, Jing Lu, Qinliang Fang, Yuyan Lu, Chengrong Xie, Huita Wu, Zhenyu Yin. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells. 2019;39
    https://doi.org/10.1042/BSR20182384
  109. Yusha Xiao, Baiyang Chen, Kang Yang, Quanxiong Wang, Pengpeng Liu, Yang Gu, Qiu Zhong, Zhisu Liu, Yueming He, Quanyan Liu. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma. Experimental Cell Research 2019;383:111542
    https://doi.org/10.1016/j.yexcr.2019.111542
  110. Phimpha Paboriboune, Thomas Vial, François Chassagne, Philavanh Sitbounlang, Sengaloun Soundala, Stéphane Bertani, Davone Sengmanothong, Francois-Xavier Babin, Nicolas Steenkeste, Paul Dény, Pascal Pineau, Eric Deharo. A Seven-Year Retrospective Study on the Surveillance of Hepatitis B in Laos. International Journal of Hepatology 2018;2018:1
    https://doi.org/10.1155/2018/9462475
  111. Mehmet Sayiner, Pegah Golabi, Zobair M. Younossi. Disease Burden of Hepatocellular Carcinoma: A Global Perspective. Dig Dis Sci 2019;64:910
    https://doi.org/10.1007/s10620-019-05537-2
  112. Fang Wang, Thomas Bank, Gregory Malnassy, Maribel Arteaga, Na Shang, Annika Dalheim, Xianzhong Ding, Scott J. Cotler, Mitchell F. Denning, Michael I. Nishimura, Peter Breslin, Wei Qiu. Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Hepatology Communications 2018;2:732
    https://doi.org/10.1002/hep4.1181
  113. Pengfei Guo, Chuipu Cai, Xiaoqin Wu, Xiude Fan, Wei Huang, Jingwei Zhou, Qihui Wu, Yujie Huang, Wei Zhao, Fengxue Zhang, Qi Wang, Yongbin Zhang, Jiansong Fang. An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.00857
  114. . Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology. Korean J Radiol 2017;18:427
    https://doi.org/10.3348/kjr.2017.18.3.427
  115. Soheil Hassanipour, Majid Mohammadzadeh, Fariborz Mansour-Ghanaei, Mohammad Fathalipour, Farahnaz Joukar, Hamid Salehiniya, Elham Abdzadeh, Ali Akbar Samadani, Hossein-Ali Nikbakht, Morteza Arab-Zozani. The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis. J Gastrointest Canc 2019;50:193
    https://doi.org/10.1007/s12029-019-00207-y
  116. Shakir Saleem, Imran Kazmi, Aftab Ahmad, Mohammed F. Abuzinadah, Ali Samkari, Huda M. Alkrathy, Ruqaiyah Khan. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats. Nutrition and Cancer 2019:1
    https://doi.org/10.1080/01635581.2019.1614199